Opis działalności
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.
Zarząd & Rada nadzorcza
| CEO |
| Jim Hollingshead |
| Zarząd |
| Wayde McMillan, Eric Benjamin, Lauren Budden, Laetitia Cousin, Patrick Crannell, Mark Field, Deborah Gordon, John Kapples, Dr. Trang Ly, Dan Manea, Prem Singh |
| Rada nadzorcza |
| Luciana Borio, Wayne A. I. Frederick, Jim Hollingshead, Jessica Hopfield, Michael R. Minogue, Corinne Nevinny, Shacey Petrovic, Timothy J. Scannell, Elizabeth Weatherman |
Dane firmy
| Nazwa: |
Insulet Corporation |
| Adres: |
100 Nagog Park,Acton, MA 01720 |
| Telefon: |
(+1) 978-600-7000 |
| Fax: |
(+1) 978-600-0120 |
| E-mail: |
-
|
| Internet: |
https://www.insulet.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Produkty Medyczne |
| Podsektor: |
- |
| Koniec roku finansowego: |
31.12 |
| Free float: |
- |
| Data IPO: |
15.05.2007 |
Relacje inwestorskie
| Nazwa: |
Deborah R. Gordon |
| Telefon: |
- |
| Fax: |
- |
| E-mail: |
ir@insulet.com
|
